Skip to content

The effects of selective neurogenic blockades on the perioperative immune reaction of patients undergoing lung resection (Pilotstudie zum einfluss selektiver neurogener blockaden auf die perioperative immunreaktion bei lungen-resezierten patienten)

The effects of selective neurogenic blockades on the perioperative immune reaction of patients undergoing lung resection (Pilotstudie zum einfluss selektiver neurogener blockaden auf die perioperative immunreaktion bei lungen-resezierten patienten)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN47414487
Enrollment
60
Registered
2007-08-02
Start date
2006-01-01
Completion date
Unknown
Last updated
2021-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung resection Surgery Lung resection

Interventions

There are three treatment arms: 1. Ropivacain 2. Remifentanil 3. Remifentanil plus Clonidin These will be given as follows:
we perform neither pre- nor post-operative interventions. The follow up period amounts to three postoperative days.

Sponsors

Charité - University Medicine Berlin (Charité - Universitätsmedizin Berlin) (Germany)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Lung resection

Exclusion criteria

Exclusion criteria: 1. Patient under age 2. Pregnancy 3. Contraindications for epidural block 4. Contraindications for ropivacain 5. Contraindications for remifantanil 6. Contraindications for clonidine 9. Treatment with local anaesthetics 10. Treatment with central anti-adrenergic drugs (clonidine, methyldopa, moxonidine, reserpine) 11. Treatment with opioids 12. Myocardial Infarction (MI) within the last eight weeks 13. Cardiac insufficiency New York Heart Association (NYHA) III and IV

Design outcomes

Secondary

MeasureTime frame
Postoperative infections, measured immediately after surgery and in the first, second and third postoperative at rounds time in the morning.

Primary

MeasureTime frame
T1/T2 ratio, measured immediately after surgery and in the first, second and third postoperative at rounds time in the morning.

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026